CLINICAL_TRIALS
trial_result
· 2023-06-29
Clinical Trial Update: A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis [Phase 3]
Summary
Phase 3 trial update for tenapanor in hyperphosphatemia among end-stage renal disease patients on dialysis; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardelyx | Conditions: Hyperphosphatemia | Phase 3 | Status: COMPLETED | Results posted: 2023-06-29